Viewing Study NCT00275132


Ignite Creation Date: 2025-12-24 @ 9:30 PM
Ignite Modification Date: 2025-12-25 @ 7:16 PM
Study NCT ID: NCT00275132
Status: COMPLETED
Last Update Posted: 2014-12-03
First Post: 2006-01-10
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Erlotinib in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer
Sponsor: University College, London
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module